Nonpharmacological Management of Autosomal Dominant Polycystic Kidney Disease

Adv Kidney Dis Health. 2023 May;30(3):220-227. doi: 10.1053/j.akdh.2022.12.008.

Abstract

Autosomal dominant polycystic kidney disease is a slowly progressive, lifelong disease characterized by continuous development and enlargement of kidney cysts. Thus, nonpharmacological interventions are crucial in disease management and have the potential for a large clinical impact as standalone interventions or in conjunction with pharmacological therapies. Current potential strategies regarding nonpharmacological management of autosomal dominant polycystic kidney disease include nonpharmacological management of blood pressure, calorie restriction, weight loss or weight management, enhanced hydration, limiting caffeine, dietary sodium restriction, protein restriction or altering the type of protein intake, phosphorus restriction, and reducing net acid load. This brief review discusses the available evidence, including cell culture, animal, epidemiological, and clinical studies, regarding the utility of such strategies in the nonpharmacological management of autosomal dominant polycystic kidney disease. We assert that lifestyle modification strategies should be a critical aspect of the treatment of autosomal dominant polycystic kidney disease, while further trial and mechanistic evidence continue to become available.

Keywords: Diet; Hydration; Obesity; Polycystic kidney disease; Sodium.

Publication types

  • Review
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Pressure
  • Kidney Neoplasms*
  • Polycystic Kidney, Autosomal Dominant* / diagnosis
  • Sodium Chloride, Dietary
  • Sodium, Dietary*

Substances

  • Sodium, Dietary
  • Sodium Chloride, Dietary